Evidence map›Paper›PMID 37739805›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2024

Metabolic Tissue Swelling and Local Microcirculation in Splanchnic Artery Occlusion Shock: Implications for Critical Illness.

Loren K Liebrecht, Jad Khoraki, Ru Li, Caitlin Archambault, John Bane, Rebecca Deitch, Michael Broadway, Gerard Eldering, Martin J Mangino

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Loren K LiebrechtDepartments of Surgery (L.K.L., J.K., R.L., C.A., J.B., R.D., M.J.M.), Respiratory Therapy (M.B.), and Physiology and Biophysics (M.J.M.), Virginia Commonwealth University, School of Medicine, Richmond, Virginia and Perfusion Medical, Inc. (L.K.L., G.E., M.J.M.), Reston, Virginia.
Jad KhorakiDepartments of Surgery (L.K.L., J.K., R.L., C.A., J.B., R.D., M.J.M.), Respiratory Therapy (M.B.), and Physiology and Biophysics (M.J.M.), Virginia Commonwealth University, School of Medicine, Richmond, Virginia and Perfusion Medical, Inc. (L.K.L., G.E., M.J.M.), Reston, Virginia.
Ru LiDepartments of Surgery (L.K.L., J.K., R.L., C.A., J.B., R.D., M.J.M.), Respiratory Therapy (M.B.), and Physiology and Biophysics (M.J.M.), Virginia Commonwealth University, School of Medicine, Richmond, Virginia and Perfusion Medical, Inc. (L.K.L., G.E., M.J.M.), Reston, Virginia.
Caitlin ArchambaultDepartments of Surgery (L.K.L., J.K., R.L., C.A., J.B., R.D., M.J.M.), Respiratory Therapy (M.B.), and Physiology and Biophysics (M.J.M.), Virginia Commonwealth University, School of Medicine, Richmond, Virginia and Perfusion Medical, Inc. (L.K.L., G.E., M.J.M.), Reston, Virginia.
John BaneDepartments of Surgery (L.K.L., J.K., R.L., C.A., J.B., R.D., M.J.M.), Respiratory Therapy (M.B.), and Physiology and Biophysics (M.J.M.), Virginia Commonwealth University, School of Medicine, Richmond, Virginia and Perfusion Medical, Inc. (L.K.L., G.E., M.J.M.), Reston, Virginia.
Rebecca DeitchDepartments of Surgery (L.K.L., J.K., R.L., C.A., J.B., R.D., M.J.M.), Respiratory Therapy (M.B.), and Physiology and Biophysics (M.J.M.), Virginia Commonwealth University, School of Medicine, Richmond, Virginia and Perfusion Medical, Inc. (L.K.L., G.E., M.J.M.), Reston, Virginia.
Michael BroadwayDepartments of Surgery (L.K.L., J.K., R.L., C.A., J.B., R.D., M.J.M.), Respiratory Therapy (M.B.), and Physiology and Biophysics (M.J.M.), Virginia Commonwealth University, School of Medicine, Richmond, Virginia and Perfusion Medical, Inc. (L.K.L., G.E., M.J.M.), Reston, Virginia.
Gerard ElderingDepartments of Surgery (L.K.L., J.K., R.L., C.A., J.B., R.D., M.J.M.), Respiratory Therapy (M.B.), and Physiology and Biophysics (M.J.M.), Virginia Commonwealth University, School of Medicine, Richmond, Virginia and Perfusion Medical, Inc. (L.K.L., G.E., M.J.M.), Reston, Virginia.
Martin J ManginoDepartments of Surgery (L.K.L., J.K., R.L., C.A., J.B., R.D., M.J.M.), Respiratory Therapy (M.B.), and Physiology and Biophysics (M.J.M.), Virginia Commonwealth University, School of Medicine, Richmond, Virginia and Perfusion Medical, Inc. (L.K.L., G.E., M.J.M.), Reston, Virginia martin.mangino@vcuhealth.org.ORCID https://orcid.org/0000-0003-2440-1952
MACOM (United States) · USVirginia Commonwealth University · US

Funding

Virus Vector Shared ResourceP30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Keri R Maher · 1985 to 2026
$51.0M
NCI NIH HHS P30 CA016059
6 · The paper itself

Abstract

Trauma is a leading cause of death in the United States. Advancements in shock resuscitation have been disappointing because the correct upstream mechanisms of injury are not being targeted. Recently, significant advancements have been shown using new cell-impermeant molecules that work by transferring metabolic water from swollen ischemic cells to the capillary, which restores tissue perfusion by microcirculatory decompression. The rapid normalization of oxygen transfer improves resuscitation outcomes. Since poor resuscitation and perfusion of trauma patients also causes critical illness and sepsis and can be mimicked by ischemia-reperfusion of splanchnic tissues, we hypothesized that inadequate oxygenation of the gut during trauma drives development of later shock and critical illness. We further hypothesized that this is caused by ischemia-induced water shifts causing compression no-reflow. To test this, the superior mesenteric artery of juvenile anesthetized swine was occluded for 30 minutes followed by 8 hours of reperfusion to induce mild splanchnic artery occlusion (SAO) shock. One group received the impermeant polyethylene glycol 20,000 Da (PEG-20k) that prevents metabolic cell swelling, and the other received a lactated Ringer's vehicle. Survival doubled in PEG-20k-treated swine along with improved macrohemodynamics and intestinal mucosal perfusion. Villus morphometry and plasma inflammatory cytokines normalized with impermeants. Plasma endotoxin rose over time after reperfusion, and impermeants abolished the rise. Inert osmotically active cell impermeants like PEG-20k improve intestinal reperfusion injury, SAO shock, and early signs of sepsis, which may be due to early restoration of mucosal perfusion and preservation of the septic barrier by reversal of ischemic compression no-reflow. SIGNIFICANCE STATEMENT: Significant advancements in treating shock and ischemia have been disappointing because the correct upstream causes have not been targeted. This study supports that poor tissue perfusion after intestinal ischemia from shock is caused by capillary compression no-reflow secondary to metabolic cell and tissue swelling since selectively targeting this issue with novel polyethylene glycol 20,000 Da-based cell-impermeant intravenous solutions reduces splanchnic artery occlusion shock, doubles survival time, restores tissue microperfusion, and preserves gut barrier function.

Indexed as

Critical IllnessSepsisAnimalsArteriesHumansIschemiaMicrocirculationPolyethylene GlycolsSplanchnic CirculationSwineWaterPolyethylene GlycolsWater

Identifiers

PMID37739805
PMCPMC10765417
OpenAlexW4386948587

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.